rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2006-8-4
|
pubmed:abstractText |
Most patients with small cell lung cancer (SCLC) usually show relapse within 1 or 2 years. Relapses after a 5-year disease-free survival are extremely rare. This report describes two patients with stage I SCLC in whom the disease recurred 10 or more years after the start of initial therapy. Because the recurrence of SCLC was noted in the mediastinal lymph nodes of the same side, we concluded that the patients had a late relapse of SCLC rather than a metachronous lung cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0368-2811
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-61
|
pubmed:meshHeading |
pubmed-meshheading:16782728-Aged,
pubmed-meshheading:16782728-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16782728-Brain Neoplasms,
pubmed-meshheading:16782728-Carcinoma, Small Cell,
pubmed-meshheading:16782728-Combined Modality Therapy,
pubmed-meshheading:16782728-Disease-Free Survival,
pubmed-meshheading:16782728-Humans,
pubmed-meshheading:16782728-Lung Neoplasms,
pubmed-meshheading:16782728-Lymph Nodes,
pubmed-meshheading:16782728-Lymphatic Metastasis,
pubmed-meshheading:16782728-Male,
pubmed-meshheading:16782728-Mediastinum,
pubmed-meshheading:16782728-Middle Aged,
pubmed-meshheading:16782728-Neoplasm Staging,
pubmed-meshheading:16782728-Neoplasms, Second Primary
|
pubmed:year |
2006
|
pubmed:articleTitle |
Relapse of stage I small cell lung cancer ten or more years after the start of treatment.
|
pubmed:affiliation |
Department of Thoracic Malignancy, Medical Center for Respiratory and Allergic Diseases of Osaka Prefecture, Osaka 583-8588, Japan. kmatsui@hbk.pref.osaka.jp
|
pubmed:publicationType |
Journal Article,
Case Reports
|